Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBPP) Asset Writedowns and Impairment (2019)

Historic Asset Writedowns and Impairment for Regen BioPharma (RGBPP) over the last 1 years, with Q1 2019 value amounting to $118121.0.

  • Regen BioPharma's Asset Writedowns and Impairment changed N/A to $118121.0 in Q1 2019 from the same period last year, while for Dec 2019 it was $118121.0, marking a year-over-year change of. This contributed to the annual value of $118121.0 for FY2019, which is N/A changed from last year.
  • Latest data reveals that Regen BioPharma reported Asset Writedowns and Impairment of $118121.0 as of Q1 2019.
  • In the past 5 years, Regen BioPharma's Asset Writedowns and Impairment registered a high of $118121.0 during Q1 2019, and its lowest value of $118121.0 during Q1 2019.